Related Articles
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
Addressing the importance of melanoma tumor‑infiltrating lymphocytes in disease progression and clinicopathological characteristics
KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin‑ or irinotecan‑based treatment
RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer
Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer